GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · IEX Real-Time Price · USD
0.284
-0.012 (-3.98%)
At close: Jul 19, 2024, 4:00 PM
0.285
+0.001 (0.18%)
Pre-market: Jul 22, 2024, 7:33 AM EDT

GlycoMimetics Revenue

GlycoMimetics had revenue of $10.00K in the twelve months ending March 31, 2024. In the year 2023, GlycoMimetics had annual revenue of $10.00K.

Revenue (ttm)
$10.00K
Revenue Growth
-86.67%
P/S Ratio
1,833.37
Revenue / Employee
$286
Employees
35
Market Cap
18.33M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.00K-65.00K-86.67%
Dec 31, 202275.00K-1.08M-93.53%
Dec 31, 20211.16M-9.00M-88.59%
Dec 31, 202010.16M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 201618.50K-20.05M-99.91%
Dec 31, 201520.07M5.04M33.56%
Dec 31, 201415.03M11.03M276.37%
Dec 31, 20133.99M-11.26M-73.83%
Dec 31, 201215.26M11.44M300.04%
Dec 31, 20113.81M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MEI Pharma 66.75M
Cara Therapeutics 16.94M
Biotricity 12.06M
Aspira Women's Health 8.99M
Synlogic 3.21M
Aeterna Zentaris 2.37M
iBio, Inc. 50.00K
Revenue Rankings